Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in Advanced, Metastatic Soft Tissue Sarcoma
NCT00918489Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- May 2010
- Primary completion
- Sep 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in soft tissue sarcoma (STS), sponsored by Heidelberg University. Started May 2010; status: completed.
02
Drugs
vorinostat
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00918489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918489.